Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Rinaldi

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Current Opinion in Pharmacology|May 16, 2018
β2-Adrenoceptor signalling bias in asthma and COPD and the potential impact on the comorbidities associated with these diseasesMaria Gabriella Matera, Clive Page, Barbara Rinaldi
Expert Opinion on Investigational Drugs|May 13, 2016
Olodaterol for the treatment of asthmaMario Cazzola, Barbara Rinaldi, Gabriella Lucà, et al.
Respiratory Medicine|October 25, 2023
Is it preferable to administer a bronchodilator once- or twice-daily when treating COPD?Maria Gabriella Matera, Barbara Rinaldi, Concetta Ambrosio, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 3, 2016
Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthmaLuigino Calzetta, Barbara Rinaldi, Mario Cazzola, et al.
Expert Review of Clinical Pharmacology|November 11, 2014
Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Paola Rogliani, Barbara Rinaldi, et al.
Expert Review of Clinical Pharmacology|November 3, 2022
Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overviewMaria Gabriella Matera, Barbara Rinaldi, Carmela Belardo, et al.
Current Opinion in Pharmacology|May 4, 2012
Treatment of COPD: moving beyond the lungsM Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 13, 2016
Assessing the viability of long-acting β<sub>2</sub>-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspectiveMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2017
Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthmaMaria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 11, 2017
Pharmacogenetic and pharmacogenomic considerations of asthma treatmentMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Current Opinion in Pharmacology|May 16, 2018
β2-Adrenoceptor signalling bias in asthma and COPD and the potential impact on the comorbidities associated with these diseasesMaria Gabriella Matera, Clive Page, Barbara Rinaldi
Expert Opinion on Investigational Drugs|May 13, 2016
Olodaterol for the treatment of asthmaMario Cazzola, Barbara Rinaldi, Gabriella Lucà, et al.
Respiratory Medicine|October 25, 2023
Is it preferable to administer a bronchodilator once- or twice-daily when treating COPD?Maria Gabriella Matera, Barbara Rinaldi, Concetta Ambrosio, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 3, 2016
Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthmaLuigino Calzetta, Barbara Rinaldi, Mario Cazzola, et al.
Expert Review of Clinical Pharmacology|November 11, 2014
Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Paola Rogliani, Barbara Rinaldi, et al.
Expert Review of Clinical Pharmacology|November 3, 2022
Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overviewMaria Gabriella Matera, Barbara Rinaldi, Carmela Belardo, et al.
Current Opinion in Pharmacology|May 4, 2012
Treatment of COPD: moving beyond the lungsM Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 13, 2016
Assessing the viability of long-acting β<sub>2</sub>-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspectiveMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2017
Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthmaMaria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 11, 2017
Pharmacogenetic and pharmacogenomic considerations of asthma treatmentMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Pageof 8